CN1381259A - Medicine for treating diseases of rectum and anus - Google Patents
Medicine for treating diseases of rectum and anus Download PDFInfo
- Publication number
- CN1381259A CN1381259A CN 02117442 CN02117442A CN1381259A CN 1381259 A CN1381259 A CN 1381259A CN 02117442 CN02117442 CN 02117442 CN 02117442 A CN02117442 A CN 02117442A CN 1381259 A CN1381259 A CN 1381259A
- Authority
- CN
- China
- Prior art keywords
- examples
- myrrha
- olibanum
- pharmaceutical composition
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000664 rectum Anatomy 0.000 title claims abstract description 7
- 210000000436 anus Anatomy 0.000 title claims abstract description 6
- 239000003814 drug Substances 0.000 title abstract description 21
- 201000010099 disease Diseases 0.000 title abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 3
- 229940079593 drug Drugs 0.000 title description 8
- 241000628997 Flos Species 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 239000004863 Frankincense Substances 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 10
- 239000009286 sanguis draxonis Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 208000025865 Ulcer Diseases 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- 231100000397 ulcer Toxicity 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000030270 breast disease Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 206010048946 Anal abscess Diseases 0.000 abstract description 6
- 208000004680 Rectal Fistula Diseases 0.000 abstract description 6
- 206010002156 anal fistula Diseases 0.000 abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 description 19
- 230000035876 healing Effects 0.000 description 11
- 208000014617 hemorrhoid Diseases 0.000 description 11
- 206010000496 acne Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000007772 internal hemorrhoid Diseases 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000032159 Vaginal inflammation Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- -1 vasodilation Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating the diseases of rectum and anus, such as perianal abscess, pile and anal fistula, is prepared from 7 Chinese medicinal materials including honeysuckle flower, wild chrysanthemum flower, prunellia spike, liquorice root, etc. Its advantages are high cure rate (99.5%), and high effective rate (99.8%), given from the evidance of 576 cases in the clinic therapy.
Description
Invention field
The present invention relates to a kind of medicine for the treatment of rectum, anus etc.
Technical field
Rectum, anus comprise perianal abscess, anal fistula, hemorrhoid etc.Because the particular tissues architectural feature at crissum position forms perianal abscess in case infect, very easily diffusion, the incision and drainage treatment usually can not be thorough, and may cause forming anal fistula, prolongedly do not heal, and makes the patient suffering can't bear.
Hemorrhoid are divided internal hemorrhoid, external hemorrhoid and mixed hemorrhoid, are the vein groups that forms owing to venous plexus blood stasis, expansion, distortion, are feature with blood, hemafecia, pain, foreign body sense of discomfort etc.The therapy of treatment hemorrhoid has a lot, comprises injection of sclerosing agent, operation etc., though these therapies are effective, exists limitation separately, and therefore therapy and the medicine for new treatment hemorrhoid still exists demand.
Summary of the invention
The present inventor is engaged in clinical position for many years, through a large amount of clinical practices, filter out a kind of effective treatment rectum, perianal, the medicine of digestive tract ulcer etc., be applied to clinical, obtained extraordinary effect, for hemorrhoid, perianal abscess, anal fistula, digestive tract ulcer, mastitis, cyclomastopathy etc. provide a kind of new therapy.
Medicine of the present invention comprises following raw material:
Flos Lonicerae 20-80 Spica Prunellae 10-60 Fructus Forsythiae 8-30
Radix Glycyrrhizae 5-30 Myrrha 4-12 Olibanum 2-10
Sanguis Draxonis 1.0-3.5 Flos Chrysanthemi Indici 4-20.
In various situations, all by weight.
The preferred weight proportioning of each raw material is:
Flos Lonicerae 30-50 Spica Prunellae 20-40 Fructus Forsythiae 10-20
Radix Glycyrrhizae 10-20 Myrrha 5-10 Olibanum 4-8
Sanguis Draxonis 1.5-2.5 Flos Chrysanthemi Indici 5-10.
The preparation method of medicine of the present invention is: Flos Lonicerae, Flos Chrysanthemi Indici water boiling concentration are gone in the surplus medicated powder end to mix thoroughly, Spica Prunellae, Radix Glycyrrhizae, Myrrha, Olibanum, Sanguis Draxonis are pulverized and are powder, dry after admixing two flavor water drug-decocting concentrating liquids, and pulverizing once again is powder, add water and shake the ball oven dry, make the watered pill.
Certainly, above-mentioned raw materials of the present invention also can be made other clinical common formulations, as oral liquid, powder, capsule etc. according to a conventional method.
Medicine of the present invention is cool in nature, sweet in the mouth, hardship, suffering.
Medicine of the present invention has that heat-clearing and toxic substances removing, eliminating stagnation stop blooding, remove the rotten and let fresh grow, the dispersing the stagnated live-QI to relieve the stagnation of QI collateral dredging, make eye bright, relieving restlessness, analgesic function.The treatment mechanism of medicine of the present invention is seven of tonneaus, and logical abdomen reason is dirty, integrally-regulated.
Medicine of the present invention can be used for treating perianal abscess, and speckle, acne removing, cyclomastopathy are gone in internal hemorrhoid, external hemorrhoid, anal fistula, perianal itch, eczema, each ulcerative hemorrhage of digestive system, bacterium dysentery and hemorrhage, beauty treatment.
Medicine of the present invention can be united use or make the Chinese medicine and western medicine compound preparation with Western medicine antibiotic, electrolyte regulator, vitamins, vasodilation, blood anticoagulant, antihypertensive drugs, it is complementary to reach associating clinically, improves curative effect and shortens treatment time.
Embodiment
Specific embodiment below is provided, has been used to illustrate the present invention, but should be clear, the invention is not restricted to these specific embodiments.
Embodiment 1
Flos Lonicerae 40g Spica Prunellae 30g Fructus Forsythiae 15g
Radix Glycyrrhizae 15g Myrrha 8g Olibanum 5g
Sanguis Draxonis 1.5g Flos Chrysanthemi Indici 8g
Flos Lonicerae, Flos Chrysanthemi Indici water boiling concentration are gone in the surplus medicated powder end to mix thoroughly, and it is 200 order powder that Spica Prunellae, Radix Glycyrrhizae, Myrrha, Olibanum, Sanguis Draxonis are pulverized, and dries after admixing two flavor water drug-decocting concentrating liquids, and pulverizing once again is 200 order powder, adds water and shakes ball and dry, and makes the watered pill.
Embodiment 2
Flos Lonicerae 45g Spica Prunellae 40g Fructus Forsythiae 20g
Radix Glycyrrhizae 10g Myrrha 5g Olibanum 5g
Sanguis Draxonis 1.5g Flos Chrysanthemi Indici 10g
Flos Lonicerae, Flos Chrysanthemi Indici water boiling concentration are gone in the surplus medicated powder end to mix thoroughly, and it is 200 order powder that Spica Prunellae, Radix Glycyrrhizae, Myrrha, Olibanum, Sanguis Draxonis are pulverized, and dries after admixing two flavor water drug-decocting concentrating liquids, and pulverizing once again is 200 order powder, adds water and shakes ball and dry, and makes the watered pill.Clinical efficacy is summed up
Perianal abscess: 4 examples.Man's 3 examples, women 1 example; Age is 25-45 year; Recovery from illness 2 examples in healing time: 5-7 days, recovery from illness 2 examples in 9-15 days.
Internal hemorrhoid: 252 examples.Man's 98 examples, women 154 examples: the age is 20-55 year; Recovery from illness 215 examples in healing time: 15-30 days, recovery from illness 37 examples in 31-40 days.
Mixed hemorrhoid: 5 examples.Man's 2 examples, women 3 examples; Age is 8-47 year; Healing time: recovery from illness 2 examples in 15 days, recovery from illness 3 examples in 20-30 days.
External hemorrhoid: 159 examples.Man's 70 examples, women 89 examples; Age is 19-51 year; Recovery from illness 94 examples in healing time: 10-20 days.Recovery from illness 65 examples in 30 days.
Anal eczema: 3 examples.Man's 1 example, women 2 examples; Age is 33-42 year; Healing time: recovery from illness 3 examples in 10 days.
Anal fistula: 53 examples.Man's 21 examples, women 32 examples; Age: 23-48 year; Healing time: recovery from illness 36 examples in 10 days, recovery from illness 16 examples in 15 days.
Bacillary dysentery " tenesmus, bloody purulent stool ": 7 examples.Man's 2 examples, women 5 examples; Age 27-65 year; Recovery from illness 7 examples in 5 days.Cooperate quiet of antibiotic etc.
Gastric ulcer: 11 examples.Man's 8 examples, women 3 examples; Age 23-49 year; Recovery from illness 11 examples in healing time: 5-20 days.
Duodenal ulcer: 17 examples.Man's 8 examples, women 9 examples; Age is 27-49 year; Recovery from illness 17 examples in healing time: 20-30 days.
Mastitis: 13 examples.Woman's 13 examples; Age 22-28 year; Healing time: recovery from illness 13 examples in 5 days.4 examples cooperate Cefazolin sodium gram, day 2 times, intramuscular injection.
Cyclomastopathy: 42 examples.Woman's 42 examples.Age 23-50 year; Healing time: recovery from illness 19 examples in 30 days, recovery from illness 18 examples in 60 days, recovery from illness 5 examples in 80 days.
Hepatitis A: 3 examples.Woman's 3 examples; Age is 11-13 year; Healing time: recovery from illness in 10 days, no clinical symptoms, biochemical analysis recovers normal 3 examples.
Urticaria: 7 examples.Man's 2 examples, women 5 examples.Age 24-42 year; Cure 2 examples in 30 days, cure 2 examples, effective 2 examples, invalid 1 example in 60 days.
From January nineteen ninety-five-1998 a year December add up above-mentioned data totally 576 examples, cure rate is 99.5%; Effective percentage is 99.9%; Inefficiency is 0.2%.
Drug use observation clinically and sex, age have nothing to do, with oral dose, disease department, the state of an illness go deep into the hobby of degree (as I, II, the III phase of hemorrhoid, the size of cyclomastopathy lump etc.), diet (as pungent diet, high caloric diet, tobacco and wine stimulation, living habit etc.), environment (home environment, working environment etc.), emotion (jealousy, excessively seek to prevail over others, miss one's aim gloomy in the heart and can not get leading off, the mental regulation ability) relevant.
The hyperpietic unites use medicine of the present invention and depressor clinically, can improve curative effect, be equal to can treating the gynaecologic vaginal inflammation with Western medicine metronidazole, nystatin, the treatment of constipation type chloasma faciei, freckle, senile plaque, comedo (acne, acne) is had better curative effect.Medicine of the present invention in a word and Western medicine are united use can play complementary effect.
Above the present invention has been described after, those skilled in the art will appreciate that under the situation that does not depart from the present invention spirit and essence, can make some variations and modification, these variations and modification all should comprise within the scope of the invention.
Claims (4)
1, a kind of pharmaceutical composition that is used for the treatment of rectum, anus, digestive tract ulcer, mastopathy is characterised in that the following raw material that comprises by weight:
Flos Lonicerae 20-80 Spica Prunellae 10-60 Fructus Forsythiae 8-30
Radix Glycyrrhizae 5-30 Myrrha 4-12 Olibanum 2-10
Sanguis Draxonis 1.0-3.5 Flos Chrysanthemi Indici 4-20.
2,, be characterised in that the weight proportion of each raw material is according to the pharmaceutical composition of claim 1:
Flos Lonicerae 30-50 Spica Prunellae 20-40 Fructus Forsythiae 10-20
Radix Glycyrrhizae 10-20 Myrrha 5-10 Olibanum 4-8
Sanguis Draxonis 1.5-2.5 Flos Chrysanthemi Indici 5-10.
3, the method for preparing the pharmaceutical composition of claim 1 or 2, comprise Flos Lonicerae, Flos Chrysanthemi Indici water boiling concentration are gone in the surplus medicated powder end to mix thoroughly, Spica Prunellae, Radix Glycyrrhizae, Myrrha, Olibanum, Sanguis Draxonis are pulverized and are powder, dry after admixing two flavor water drug-decocting concentrating liquids, pulverize once again and be powder, add water and shake the ball oven dry, make the watered pill.
4,, be characterised in that it is any of clinical common formulations according to the pharmaceutical composition of claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021174423A CN1169561C (en) | 2002-05-16 | 2002-05-16 | Medicine for treating diseases of rectum and anus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021174423A CN1169561C (en) | 2002-05-16 | 2002-05-16 | Medicine for treating diseases of rectum and anus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1381259A true CN1381259A (en) | 2002-11-27 |
| CN1169561C CN1169561C (en) | 2004-10-06 |
Family
ID=4744426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021174423A Expired - Fee Related CN1169561C (en) | 2002-05-16 | 2002-05-16 | Medicine for treating diseases of rectum and anus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1169561C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579788A (en) * | 2012-03-22 | 2012-07-18 | 解瑞东 | Medicinal composition for treating peptic ulcer |
| CN104055854A (en) * | 2013-03-21 | 2014-09-24 | 梅广浦 | Traditional Chinese medicine composition capable of removing acne |
| CN105079112A (en) * | 2015-09-16 | 2015-11-25 | 崔世义 | Traditional Chinese medicinal preparation for postoperative treatment of anorectal abscess |
| CN105168717A (en) * | 2015-10-10 | 2015-12-23 | 临沂草之美医药科技有限公司 | A kind of traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof |
| CN105213686A (en) * | 2015-10-24 | 2016-01-06 | 孙桂芝 | A kind of qi stagnation and blood stasis type hemorrhoid treating cream |
| CN106822708A (en) * | 2017-02-14 | 2017-06-13 | 上海台浦合能实业有限公司 | A kind of Chinese medicine according to determining female physiological periodicity change treatment gynecological disease |
| CN107753812A (en) * | 2017-12-08 | 2018-03-06 | 车同武 | Hemorrhoid oral traditional Chinese medicine medicine materical crude slice and preparation method thereof |
| CN111345471A (en) * | 2018-12-24 | 2020-06-30 | 广州王老吉药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of food, medicine or health-care product with effect of reducing senile plaques |
-
2002
- 2002-05-16 CN CNB021174423A patent/CN1169561C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579788A (en) * | 2012-03-22 | 2012-07-18 | 解瑞东 | Medicinal composition for treating peptic ulcer |
| CN104055854A (en) * | 2013-03-21 | 2014-09-24 | 梅广浦 | Traditional Chinese medicine composition capable of removing acne |
| CN105079112A (en) * | 2015-09-16 | 2015-11-25 | 崔世义 | Traditional Chinese medicinal preparation for postoperative treatment of anorectal abscess |
| CN105168717A (en) * | 2015-10-10 | 2015-12-23 | 临沂草之美医药科技有限公司 | A kind of traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof |
| CN105213686A (en) * | 2015-10-24 | 2016-01-06 | 孙桂芝 | A kind of qi stagnation and blood stasis type hemorrhoid treating cream |
| CN106822708A (en) * | 2017-02-14 | 2017-06-13 | 上海台浦合能实业有限公司 | A kind of Chinese medicine according to determining female physiological periodicity change treatment gynecological disease |
| CN107753812A (en) * | 2017-12-08 | 2018-03-06 | 车同武 | Hemorrhoid oral traditional Chinese medicine medicine materical crude slice and preparation method thereof |
| CN111345471A (en) * | 2018-12-24 | 2020-06-30 | 广州王老吉药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of food, medicine or health-care product with effect of reducing senile plaques |
| CN111345471B (en) * | 2018-12-24 | 2022-07-19 | 广州王老吉药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine with effect of reducing senile plaques |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1169561C (en) | 2004-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169561C (en) | Medicine for treating diseases of rectum and anus | |
| US7354570B2 (en) | Chinese preparation for treating enteritis ulcer colitis and preparation method thereof | |
| WO2024001141A1 (en) | Use of herba agastachis stomach-calming prescription in preparation of drug for resisting helicobacter pylori | |
| CN101028490A (en) | Chinese medicine for treating acne | |
| CN1284585C (en) | Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method | |
| CN113908212A (en) | Traditional Chinese medicine composition for treating small intestinal mucosa injury caused by non-steroidal anti-inflammatory drugs, preparation method and preparation thereof | |
| CN1709302A (en) | Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease and preparation method thereof | |
| RU2124362C1 (en) | Suppository and an ointment containing celandine herb extract and a method of treatment of patients with hemorrhoid | |
| CN110772568A (en) | Traditional Chinese medicine composition for treating radiation enteritis and preparation method thereof | |
| CN118078894B (en) | A Chinese medicine composition for preventing and treating postoperative complications of hemorrhoids | |
| CN112972559B (en) | Traditional Chinese medicine composition and traditional Chinese medicine mixture for treating bone and soft tissue suppurative inflammation | |
| CN1533795A (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
| CN1391950A (en) | Acne clearing liquid | |
| CN1308031C (en) | Chinese medicine composition for treating biliary tract disease, preparing method and use | |
| CN1939470A (en) | Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions | |
| CN108524697A (en) | A kind of drug for treating prostatitis and hyperplasia | |
| CN1084748A (en) | Quick results arthritis dressing and manufacture method thereof | |
| CN100427121C (en) | Blood jerky and blood jerky total flavonoids solution-type preparation and preparation method thereof | |
| CN120570951A (en) | A chrysanthemum detoxification lotion for promoting wound healing and a preparation method thereof | |
| CN118576657A (en) | A compound preparation for treating toothache | |
| CN118593608A (en) | Traditional Chinese medicine composition for treating malignant tumors and its application | |
| CN1137397A (en) | Xinli nose drops and preparation method thereof | |
| CN119033891A (en) | Traditional Chinese medicine composition for treating hypotension and its preparation method and application | |
| CN119896692A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN119896704A (en) | A Chinese medicine composition for quickly curing oral ulcers and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |